Centralized Reminder/Recall to Increase Influenza Vaccination Rates: A Two-State Pragmatic Randomized Trial.


Journal

Academic pediatrics
ISSN: 1876-2867
Titre abrégé: Acad Pediatr
Pays: United States
ID NLM: 101499145

Informations de publication

Date de publication:
04 2020
Historique:
received: 16 07 2019
revised: 28 10 2019
accepted: 30 10 2019
pubmed: 8 11 2019
medline: 18 3 2021
entrez: 8 11 2019
Statut: ppublish

Résumé

Centralized reminder/recall (C-R/R) by health departments using immunization information systems is more effective and cost effective than practice-based approaches for increasing childhood vaccines but has not been studied for influenza vaccination. We assessed effectiveness and cost of C-R/R for increasing childhood influenza vaccination compared with usual care. Within Colorado (CO) and New York (NY), random samples of primary care practices (pediatric, family medicine, and health center) were selected proportionate to where children are served-65 practices (N = 54,353 children) in CO; 101 practices (N = 65,777) in NY. We conducted 4-arm RCTs per state (1, 2, or 3 autodial reminders vs usual care), with randomization at the patient level within practices from 10/2016 to 1/2017. In CO, the maximum absolute difference in receipt of ≥1 influenza vaccine was 1.7% between the 2 R/R group and control (adjusted risk ratio [ARR] of 1.06 [1.01, 1.10]); other R/R arms did not differ significantly. In NY, ARRs for the study arms versus control varied from 1.05 (1.01, 1.10) for 3 R/R to 1.06 (1.01, 1.11) for 1-2 R/R groups and maximum absolute increase in vaccination was 0.6%. In time-to-event analyses, study arm was a significant predictor of vaccination in CO (P = .001) but not in NY. Costs/child randomized to one message were $.17 in CO and $.23 in NY. C-R/R for influenza vaccine using autodial had low-level effects on increasing influenza rates in 2 states. Given the feasibility and low cost of C-R/R in previous trials, its utility for influenza should be re-examined using different modalities.

Identifiants

pubmed: 31698085
pii: S1876-2859(19)30449-8
doi: 10.1016/j.acap.2019.10.015
pmc: PMC7477488
mid: NIHMS1541989
pii:
doi:

Substances chimiques

Influenza Vaccines 0

Banques de données

ClinicalTrials.gov
['NCT02761551', 'NCT02924467']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

374-383

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI114903
Pays : United States

Informations de copyright

Copyright © 2019 Academic Pediatric Association. Published by Elsevier Inc. All rights reserved.

Références

JAMA Pediatr. 2015 Apr;169(4):365-73
pubmed: 25706340
N Engl J Med. 2006 Jul 6;355(1):31-40
pubmed: 16822994
BMC Med Inform Decis Mak. 2012 Dec 17;12:145
pubmed: 23245381
Pediatrics. 2005 Jan;115(1):146-54
pubmed: 15629993
MMWR Recomm Rep. 2017 Aug 25;66(2):1-20
pubmed: 28841201
J Adolesc Health. 2018 Feb;62(2):157-163
pubmed: 29248390
Pediatrics. 2003 Nov;112(5):1076-82
pubmed: 14595049
Euro Surveill. 2013 Jan 31;18(5):
pubmed: 23399425
Vaccine. 2018 Aug 6;36(32 Pt B):4904-4909
pubmed: 30037480
JAMA. 2012 Apr 25;307(16):1702-8
pubmed: 22535855
MMWR Recomm Rep. 2018 Aug 24;67(3):1-20
pubmed: 30141464
MMWR Morb Mortal Wkly Rep. 2010 Apr 30;59(16):477-84
pubmed: 20431523
JAMA. 2000 Oct 11;284(14):1820-7
pubmed: 11025835
Acad Pediatr. 2016 Jan-Feb;16(1):50-6
pubmed: 26525988
Cochrane Database Syst Rev. 2018 Jan 18;1:CD003941
pubmed: 29342498
MMWR Morb Mortal Wkly Rep. 2015 Jan 16;64(1):10-5
pubmed: 25590680
Acad Pediatr. 2018 Mar;18(2S):S72-S78
pubmed: 29502641
PLoS One. 2017 Jan 26;12(1):e0170550
pubmed: 28125629
Pediatrics. 2016 Mar;137(3):e20153280
pubmed: 26908692
MMWR Recomm Rep. 2008 Aug 8;57(RR-7):1-60
pubmed: 18685555
Clin Infect Dis. 2020 Jun 10;70(12):2496-2502
pubmed: 31344229
Acad Pediatr. 2018 Nov - Dec;18(8):873-881
pubmed: 30031132
Acad Pediatr. 2011 Jan-Feb;11(1):44-9
pubmed: 21272823
Vaccine. 2015 Apr 8;33(15):1802-7
pubmed: 25744225
MMWR Recomm Rep. 2013 Sep 20;62(RR-07):1-43
pubmed: 24048214
J Infect Dis. 2002 Jan 15;185(2):147-52
pubmed: 11807687
BMC Public Health. 2006 Feb 15;6:33
pubmed: 16480494
Am J Public Health. 2013 Jun;103(6):1116-23
pubmed: 23237154
Lancet Infect Dis. 2013 Jan;13(1):7-9
pubmed: 23257219
Am J Prev Med. 2000 Jan;18(1 Suppl):97-140
pubmed: 10806982
Acad Pediatr. 2014 May-Jun;14(3):234-40
pubmed: 24767776
Am J Prev Med. 2012 Jan;42(1):71-5
pubmed: 22176850

Auteurs

Allison Kempe (A)

Adult and Child Consortium for Health Outcomes Research and Delivery Science (ACCORDS), University of Colorado School of Medicine and Children's Hospital Colorado (A Kempe, AW Saville, L Helmkamp, LM Dickinson, and D Gurfinkel), Aurora, Colo; Department of Pediatrics, University of Colorado School of Medicine (A Kempe), Aurora, Colo. Electronic address: allison.kempe@childrenscolorado.org.

Alison W Saville (AW)

Adult and Child Consortium for Health Outcomes Research and Delivery Science (ACCORDS), University of Colorado School of Medicine and Children's Hospital Colorado (A Kempe, AW Saville, L Helmkamp, LM Dickinson, and D Gurfinkel), Aurora, Colo.

Christina Albertin (C)

Department of Pediatrics, UCLA Mattel Children's Hospital, University of California at Los Angeles (C Albertin and P Szilagyi), Los Angeles, Calif.

Laura Helmkamp (L)

Adult and Child Consortium for Health Outcomes Research and Delivery Science (ACCORDS), University of Colorado School of Medicine and Children's Hospital Colorado (A Kempe, AW Saville, L Helmkamp, LM Dickinson, and D Gurfinkel), Aurora, Colo.

Xinkai Zhou (X)

Department of Medicine, Statistics Core, David Geffen School of Medicine, University of California (X Zhou, S Vangela, and C-H Tseng), Los Angeles, Calif.

Sitaram Vangela (S)

Department of Medicine, Statistics Core, David Geffen School of Medicine, University of California (X Zhou, S Vangela, and C-H Tseng), Los Angeles, Calif.

L Miriam Dickinson (LM)

Adult and Child Consortium for Health Outcomes Research and Delivery Science (ACCORDS), University of Colorado School of Medicine and Children's Hospital Colorado (A Kempe, AW Saville, L Helmkamp, LM Dickinson, and D Gurfinkel), Aurora, Colo; Department of Family Medicine, University of Colorado School of Medicine (LM Dickinson), Aurora, Colo.

Chi-Hong Tseng (CH)

Department of Medicine, Statistics Core, David Geffen School of Medicine, University of California (X Zhou, S Vangela, and C-H Tseng), Los Angeles, Calif.

Jonathan D Campbell (JD)

Department of Clinical Pharmacy, University of Colorado Anschutz Medical Campus (JD Campbell and M Whittington), Aurora, Colo.

Melanie Whittington (M)

Department of Clinical Pharmacy, University of Colorado Anschutz Medical Campus (JD Campbell and M Whittington), Aurora, Colo.

Dennis Gurfinkel (D)

Adult and Child Consortium for Health Outcomes Research and Delivery Science (ACCORDS), University of Colorado School of Medicine and Children's Hospital Colorado (A Kempe, AW Saville, L Helmkamp, LM Dickinson, and D Gurfinkel), Aurora, Colo.

Heather Roth (H)

Colorado Immunization Information System, Colorado Department of Public Health and Environment (H Roth), Denver, Colo.

Dina Hoefer (D)

New York State Immunization Information System, New York State Department of Health (D Hoefer), Albany, NY.

Peter Szilagyi (P)

Department of Pediatrics, UCLA Mattel Children's Hospital, University of California at Los Angeles (C Albertin and P Szilagyi), Los Angeles, Calif.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH